Using mRNA technology like that in the COVID-19 vaccines, researchers have demonstrated a successful way to deliver a potential HIV vaccine, researchers at Duke Human Vaccine Institute report.
Mar 16, 2022
0
173
The Ebola virus can hide in the brains of monkeys that have recovered after medical treatment without causing symptoms and lead to recurrent infections, according to a study by a team I led that was published in the journal ...
Mar 16, 2022
0
22
Tyler Sandberg, Center for Infectious Medicine (CIM) at the Department of Medicine, Huddinge is defending his thesis "B cell responses to human flavivirus vaccination and SARS-CoV-2 infection" on March 18, 2022. Main Supervisor ...
Mar 14, 2022
0
30
Q: My son tested positive for COVID-19. Does he still need the vaccine?
Mar 14, 2022
0
4
The antiviral therapies remdesivir, molnupiravir, and the active ingredient in Pfizer's Paxlovid pill (nirmatrelvir), remain effective in laboratory tests against the BA.2 variant of SARS-CoV-2, the virus that causes COVID-19.
Mar 10, 2022
0
123
Only one currently authorized antibody treatment retains its activity against all Omicron subvariants, according to new research by scientists at Columbia University and the University of Hong Kong. The study also shows that ...
Mar 3, 2022
0
40
Nirsevimab showed 74.5 percent efficacy against medically attended lower respiratory tract infections caused by respiratory syncytial virus (RSV) in healthy infants, according to an international, randomized, placebo-controlled ...
Mar 2, 2022
0
788
Intensive treatment for patients with Crohn's disease showed no safety differences compared to the current standard of care, according to a trial published in the journal Gastroenterology.
Mar 2, 2022
0
6
One of the major successes of decades of cancer research has been the development of drugs that specifically inactivate oncogenes, genes that function abnormally, causing cells to behave erratically, become malignant and ...
Mar 1, 2022
0
59
For patients with symptomatic COVID-19, treatment with nirmatrelvir plus ritonavir results in a lower risk for progression to severe COVID-19, according to a study published online Feb. 16 in the New England Journal of Medicine.
Mar 1, 2022
0
3
